EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Interplay between Integrins and Immune Cells as a Regulator in Cancer Immunology

Qingfang Zhang, Shuo Zhang, Jianrui Chen, Zhenzhen Xie

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24076170 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Qingfang Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical, Nanchang University, Nanchang 330006, China. Hauptthemen laut MEDLINE: Disease Progression, Immunotherapy, Integrins, Neoplasms. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 252 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Integrins are a group of heterodimers consisting of α and β subunits that mediate a variety of physiological activities of immune cells, including cell migration, adhesion, proliferation, survival, and immunotolerance. Multiple types of integrins act differently on the same immune cells, while the same integrin may exert various effects on different immune cells. In the development of cancer, integrins are involved in the regulation of cancer cell proliferation, invasion, migration, and angiogenesis; conversely, integrins promote immune cell aggregation to mediate the elimination of tumors. The important roles of integrins in cancer progression have provided valuable clues for the diagnosis and targeted treatment of cancer. Furthermore, many integrin inhibitors have been investigated in clinical trials to explore effective regimens and reduce side effects. Due to the complexity of the mechanism of integrin-mediated cancer progression, challenges remain in the research and development of cancer immunotherapies (CITs). This review enumerates the effects of integrins on four types of immune cells and the potential mechanisms involved in the progression of cancer, which will provide ideas for more optimal CIT in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease ProgressionImmunotherapyIntegrinsNeoplasmsImmune SystemAnimalsHumansB-LymphocytesDendritic CellsKiller Cells, NaturalMacrophagesNeutrophilsT-Lymphocytes

Stichwörter der Autor:innen

cancercancer immunotherapyimmune cellsimmunityintegrins

Substanzen

Integrins

Autor:innen und Institutionen

  • College of Basic Medical, Nanchang University, Nanchang 330006, China.
  • Queen Mary School, Medical Department, Nanchang University, Nanchang 330031, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Q., Zhang, S., Chen, J., & Xie, Z. (2023). The Interplay between Integrins and Immune Cells as a Regulator in Cancer Immunology. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076170

Vancouver

Zhang Q, Zhang S, Chen J, Xie Z. The Interplay between Integrins and Immune Cells as a Regulator in Cancer Immunology. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076170

BibTeX
@article{Zhang2023,
  author = {Zhang, Qingfang and Zhang, Shuo and Chen, Jianrui and Xie, Zhenzhen},
  title = {The Interplay between Integrins and Immune Cells as a Regulator in Cancer Immunology},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24076170}
}
Kostenlos starten →